A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
Status:
Completed
Trial end date:
2022-07-29
Target enrollment:
Participant gender:
Summary
This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate
HTX-011 compared with bupivacaine HCl in subjects undergoing Total Shoulder Arthroplasty
(TSA) (Cohort 1).